Mesna (Mylan Institutional LLC)


Welcome to the PulseAid listing for the Mesna drug offered from Mylan Institutional LLC. This Cytoprotective Agent [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Mylan Institutional LLC
NON-PROPRIETARY NAME: mesna
SUBSTANCE NAME: MESNA
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Cytoprotective Agent [EPC]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2012-04-03
END MARKETING DATE: 0000-00-00


Mesna HUMAN PRESCRIPTION DRUG Details:

Item DescriptionMesna from Mylan Institutional LLC
LABELER NAME: Mylan Institutional LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 100(mg/mL)
START MARKETING DATE: 2012-04-03
END MARKETING DATE: 0000-00-00
PRODUCT ID: 67457-148_15c1ed57-8210-4ae4-a19c-761cf64a56f0
PRODUCT NDC: 67457-148
APPLICATION NUMBER: ANDA076488

Other MESNA Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Baxter Healthcare CorporationMESNEX
Fresenius Kabi USA, LLCMesna
Mylan Institutional LLCMesna
Sagent PharmaceuticalsMesna
Teva Parenteral Medicines, Inc.Mesna